Alpha-ketoglutarate decreases serum levels of C-terminal cross-linking telopeptide of type I collagen (CTX) in postmenopausal women with osteopenia: Six-month study

International Journal for Vitamin and Nutrition Research

Volumn 77, Issue 2, 2007, Pages 89-97

  Filip, Rafał S ^a   Pierzynowski, Stefan G ^b   Lindegard, Birger ^c   Wernerman, Jan ^d   Haratym Maj, Agnieszka ^a   Podgurniak, Małgorzata ^e  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Bone mineral density (BMD); C terminal cross linking telopeptide of type I collagen; Osteocalcin; Osteopenia; ketoglutarate

Indexed keywords

2 OXOGLUTARIC ACID; CALCIUM SALT; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; PLACEBO;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BACKACHE; BONE DENSITY; BREAST CANCER; CHOLELITHIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; HUMAN; HYDRONEPHROSIS; MAJOR CLINICAL STUDY; METRORRHAGIA; OSTEOPENIA; POSTMENOPAUSE; RADICULOPATHY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; VITREOUS HEMORRHAGE;

EID: 34250891909     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.77.2.89     Document Type: Article

References (65)

1. Imai, S. and Matsue, Y. (2002) Neuronal regulation of bone metabolism and anabolism: calcitonin gene related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and bone. Microsc. Res. Tech. 58, 61-69.
2. Heiskanen, J. T., Kröger, H., Pääkkönen, M., Parviainen, M. T., Lamberg-Allard, C. and Alhava, E. (2001) Bone mineral metabolism after total gastrectomy. Bone 28, 123-127.
3. Shmidmaier, G., Wildemann, B., Gabelein, T., Heeger, J., Kandziora, F. and Hass, N. P. (2003) Synergistic effect of IGF-1 and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-1 and TGF-beta1. Octa. Orthop. Scand. 74, 604-610.
4. Moukarzel, A. A., Goulet, O., Salas, J. S., Marti-Henneberg, C., Buchman, A. L., Cynober, L. et al. (1994) Growth retardation in children receiving long-term total parenteral nutrition: effects of ornithine alpha-ketoglutarate. Am. J. Clin. Nutr. 60, 408-143.
5. Malyszko, J., Malyszko, J. S., Wolczynski, S. and Mysliwiec, M. (2003) Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. Transplant. Proc. 35, 2227-2229.
6. Radzki, R. P., Bienko, M., Puzio, I., Filip, R., Pierzynowski, S. G. and Studzinski, T. (2002) The effect of alpha-ketoglutarate (AKG) on mineralization of femur in ovariectomized rats. Acta Orthop. Scand. 73, 52.
7. Harrison, A. P., Tygesen, M. P., Sawa-Wojtanowicz, B., Husted, S. and Tatara, M. R. (2004) α-ketoglutarate treatment early in postnatal life improves bone density in lambs at slaughter. Bone 35, 204-209.
8. Riedel, E., Nündel, M. and Hampl, H. (1996) α-ketoglutarate application in hemodialysis patients improves amino acid metabolism. Nephron 74, 261-265.
9. Riedel, E., Hampl, H., Steudle, V. and Nündel, M. (1996) Calcium Alpha-ketoglutarate administration to malnutritioned hemodialysis patients improves plasma arginine concentration. Miner. Electrolyte. Metab. 22, 119-122.
10. Diegelmann, R. F. (2003) Analysis of collagen synthesis. Methods. Mol. Med. 78, 349-358.
11. Cynober, L., Coudray-Lucas, C., De Bandt, J. P. et al. (1990) Action of ornithine α-ketoglutarate, ornithine hydrochloride and calcium α-ketoglutarate on plasma amino acid and hormonal patterns in healthy subjects. J. Am. Coll. Nutr. 9, 2-12.
12. Stoll, B., Burrin, D. G., Henry, J., Hung, Y., Jahoor, F. and Reeds, P. J. (1999) Substrate oxidation by the portal drained viscera of fed piglets. Am. J. Physiol. 277, 168-175.
13. Matthews, D. E., Marano, M. A. and Campbell, R. G. (1993) Splanchnic bed utilization of glutamine and glutamic acid in humans. Am. J. Physiol. 264, 848-854.
14. Le Bricon, T., Coudray-Lucas, C., Lioret, N. et al. (1997) Ornithine alphaketoglutarate metabolism after enteral administration in burn patients: bolus compared with continuous infusion. Am. J. Clin. Nutr. 65, 512-518.
15. Kristensen, N. B., Jungvid, H., Fernandes, J. A. and Pierzynowski, S. G. (2002) Absorption and metabolism of alpha-ketoglutarate in growing pigs. J. Anim. Physiol. Nut. 86, 1-7.
16. Aussel, C., Coudray-Lucas, C., Lasnier, E., Cynober, L. and Ekindjan, O. G. (1996) α-ketoglutarate uptake in human fibroblasts. Cell. Biol. Int. 20, 359-363.
17. Stoll, B., McNelly, S., Busher, H. P. and Haussinger, D. (1991) Functional hepatocyte heterogenicity in glutamate, aspartate and α-ketoglutarate uptake: a histoautoradiographic study. Hepatology 13, 247-253.
18. Welborn, J. R., Shpun, S., Dantzler, W. H. and Wright, S. H. (1998) Effect of α-ketoglutarate on organic anion transport in single rabbit renal proximal tubules. Am. J. Physiol. 274, 165-174.
19. Stoll, B. and Häussinger, D. (1998) Functional hepatocyte heterogeneity. Vascular 2-oxoglutarate is almost exclusively taken up by perivenous glutamine-synthetase-containing hepatocytes. Eur. J. Biochem. 181, 709-16.
20. Lambert, B., Stoll, B., Niinikoski, H., Pierzynowski, S. and Burrin, D. G. (2002) Net portal absorption of enterally fed alpha-ketoglutarate is limited in young pigs. J. Nutr. 132, 3383-3386.
21. Petersen, L., Olewinski, R., Salmon, P. and Connors, N. (2003) Novel proline hydroxylase activities in the pneumocandin-producing fungus Glarea lozoyensis responsible for the formation of trans 3- and trans 4-hydroxyproline. Appl. Microbiol. Biotechnol. 62, 263-267.
22. Majamaa, K., Sasaki, T. and Uitto, J. (1987) Inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures by ethyl 3,4-dihydroxybenzoate. J. Invest. Dermatol. 89, 405-409.
23. Lambert, B. D., Stoll, B., Niinikoski, H., Pierzynowski, S. and Burrin, D. G. (2005) Net portal absorption of duodenally infused α-ketoglutarate is limited in young pigs. J. Nutr. submitted.
24. Parikka, V. Lehenkari, P., Sassi, M. L. et al. (2001) Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology 142, 5371-5378.
25. Dominguez, L. J., Barbagallo, M. and Moro, L. (2005) Collagen overglycosylation: a biochemical feature that may contribute to bone quality. Biochem. Biophys. Res. Commun. 29, 1-4.
26. Varila, E., Rantala, I., Oikarinen, A., Risteli, J., Reunalla, T., Oksanen, H. and Punnonen, R. (1995) The effect of topical oestradiol on skin collagen of postmenopausal women. Br. J. Obstet. Gynecol. 102, 985-989.
27. Soderberg, M. W., Falconer, C., Bystrom, B., Malmstrom, A. and Ekman, G. (2004) Young women with genital prolapse have a low collagen concentration. Acta Obstet. Gynecol. Scand. 83, 1193-1198.
28. Deprez, X. and Fardellone, P. (2003) Nonpharmacological prevention of osteoporotic fractures. Joint Bone Spine 70, 448-457.
29. Larkey, L. K., Day, S. H., Houtkooper, L. and Renger, R. (2003) Osteoporosis prevention: knowledge and behaviour in a southwestern community. J. Community Health 28, 377-88.
30. Dequeker, J., Ranstam, J., Valsson, J., Sigurgevisson, B. and Allander, E. (1991) The Mediterranean Osteoporosis (MEDOS) Study questionnaire. Clin. Rheumatol. 10, 54-72.
31. Tsubono, Y., Ogawa, K., Watanabe, Y. Nishino, Y. Tsuji, I., Watanabe, T., Nakatsuka, H., Takahashi, N., Kawamura, M. and Hisamichi, S. (2001) Nutr. Cancer 39, 78-84.
32. Filip, R. and Zagórski, J. (2001) Bone mineral density and osteoporosis in rural and urban women. Epidemiological study of the Lublin region (eastern Poland). A.A.E.M. 8, 221-226.
33. Ravn, P., Rix, M., Anderssen, H., Clemmesen, B., Bidstrup, M. and Gunnes, M. (1997) High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women. Calcif. Tissue Int. 60, 255-260.
34. Garnero, P., Sornay-Rendu, E., Chapuy, M. C. and Delmas, P. D. (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J. Bone Miner. Res. 11, 337-349.
35. Hannon, R. A. and Eastell, R. (2003) Biochemical markers of bone turnover and fracture prediction. J. Br. Menopause Soc. 9, 10-15.
36. Chapurlat, R. D., Garnero, P., Breart, G., Meunier, P. J. and Delmas, P. D. (2000) Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. Bone 27, 283-286.
37. Bruyre, O., Collete, J., Delmas, P. et al. (2003) Interest on of new vertebral fracture in postmenopausal osteoporotic women. Maturitas 44, 259-65.
38. Delmas, P. D. (2000) Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs. Osteoporosis Int. 6, 66-76.
39. Russel, R. G. and Rogers, M. J. (1999) Bisphosphonates: from the laboratory to the clinic and back again. Bone 25, 97-106.
40. Report of a WHO study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 1994, Geneva 843.
41. Kärkkáinen, M., Lamberg-Allardt, C. H., Ahonen, S. and Válimáki, M. (2001) Does it make a difference how and when you take your calcium? The acute effects of calcium on calcium and bone metabolism. Am. J. Clin. Nutr. 74, 335-342.
42. Ulrich, U., Miller, P. B., Eyre, D. R. et al. (2003) Short term calcium supplementation has no effect on biochemical markers of bone remodeling in early postmenopausal women. Arch. Gynecol. Obstet. 270, 230-234.
43. Srivastava, A. K., Libanati, C., Hohmann, O., Kriegman, A. and Baylink, D. J. (2004) Acute effects of calcitonin nasal spray on serum C-telopeptide of type 1 collagen (CTx) levels in elderly osteopenic women with increased bone turnover. Calcif. Tissue Int. 75, 477-481.
44. Delmas, P. D. (2000) Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs. Osteoporosis Int. 11, 66-76.
45. Eastel, R., Barton, I., Hannon, R. A., Chines, A., Garnero, P. and Delmas, P. D. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J. Bone Miner. Res. 18, 1051-1056.
46. Christgau, S., Bitsch-Jensen, O., Hanover Bjarnason, N., Gamwell-Henriksen, E., Qvist, P., Alexandresen, P. and Bang-Henriksen, D. (2000) Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy. Bone 26, 505-511.
47. Meunier, P. J., Roux, C., Seeman, E., Ortolani, S., Badurski, J. E., Spector, T. D., Cannata, J., Balogh, A., Lemmel, E. M., Pors-Nielsen, S., Rizzoli, R., Genant, H. K. and Reginster, J. Y. (2004) The effect of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N. Engl. J. Med. 350, 459-468.
48. Hodsman, A. B., Hanley, D. A., Ettinger, M. P., Bolognese, M. A., Fox, J., Metcalfe, A. J. and Lindsay, R. (2003) Efficacy and safety of human parathyroid hormone (1-84) in increasing bone mineral density in postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 88, 5212-5220.
49. Heaney, R. P. (1996) Bone mass, nutrition, and other lifestyle factors. Nutr. Rev. 54, 3-10.
50. Woitge, H. W., Scheigt-Nave, C., Kissling, C. et al. (1998) Seasonal variation of biochemical indexes of bone turnover: results of a population based study. J. Clin. Endocrinol. Metab. 83, 68-75.
51. Weisman, S. M. and Matkovic, V. (2005) Potential use of biochemical markers of bone turnover for assessing the effect of calcium supplementation and predicting fracture risk. Clin. Ther. 27, 299-308.
52. Tatara, M. R., Sli wa, E., Krupski, W., Brodzki, A. and Pasternak, K. (2006) Ornithine alpha-ketoglutarate increases mineralization and mechanical properties of tibia in turkeys. Bone (on-line).
53. Tatara, M. R., Pierzynowski, S.G., Silmanowicz, P. and Studzinski, T. (2003) The influence of alpha-ketoglutarate (AKG) administration on mineralisation, mechanical and geometrical properties after experimental denervation of the ulna bone in the turkey. Calcif. Tissue. Int. 72, 437.
54. Woo, T. and Adachi, J. D. (2001) Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis. Best Pract. Res. Clin. Rheumatol. 15, 469-481.
55. Dennison, E., Eastell, R., Fall, H. D., Kellingray, S., Wood, P. J. and Cooper, C. (1999) Determinants of bone loss in elderly men and women: A prospective population study. Osteoporosis Int. 10, 384-391.
56. Guyatt, G. H., Cranney, A., Griffith, L. et al. (2002) Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures. Endocrinol. Metab. Clin. North Am. 31, 659-79.
57. Boonen, S., Haentjents, P., Vandenput, L. and Vanderschuen, D. (2004) Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes. J. Intern. Med. 255, 1-12.
58. Marcus, R., Wong, M., Heath, H. and Stock, J. L. (2002) Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocr. Rev. 23, 16-37.
59. Chesnut III, C. H., Silverman, S., Adriano, K. et al. (2000) A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am. J. Med. 109, 267-276.
60. Lufkin, E. G., Whitaker, M. D., Nickelsen, T. et al. (1998) Treatment of established postmenopausal osteoporosis with raloxiphene: a randomized trial. J. Bone Miner. Res. 13, 1747-1754.
61. Lambert, B. D., Filip, R., Stoll, B., Niinikoski, H., Sunehag, A., Junghans, P., Derno, M., Hennig, U., Souffrant, W. B., Pierzynowski, S. G. and Burrin, D. G. (2005) First - pass metabolism limits the intestinal absorption of enterally infused α-ketoglutarate in pigs. J. Nutr. 136, 2779-84.
62. Chapuy, M. C., Arlot, M. E., Delmas, P. D. and Meunier, P. J. (1994) Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. B.M.J. 308, 1081-1082.
63. Dawson-Hughes, B., Harris, S. S., Krall, E. A. and Dallal, G. E. (1997) Effect of calcium and vitamin D supplementation on bone mineral density in men and women 65 years of age or older. N. Engl. J. Med. 337, 670-676.
64. Reid, I. R., Ames, R. W., Evans, M. C., Gamble, G. D. and Sharpe, S. J. (1995) Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am. J. Med. 98, 331-335.
65. Lee, W. T. K., Leung, S. S. F., Leung, D. M. Y. and Cheng, J. C. Y. (1996) A follow-up study on the effects of calcium-supplement withdrawal and puberty on bone acquisition of children. Am. J. Clin. Nutr. 64, 71-7.